Previous 10 | Next 10 |
Movano Completes Blood Pressure Study with 110 Participants The Company plans to execute its second glucose clinical study in the first quarter of 2022 PR Newswire PLEASANTON, Calif. , Jan. 3, 2022 /PRNewswire/ -- Movano Inc . (NASDAQ:MOVE), a...
Movano Unveils Smart Ring Designed for Women Seeking More Approachable Health Insights Intelligent and affordable female-focused device correlates your daily habits with how you feel, so you can make smarter health choices to become the ultimate version of you PR Newswire ...
Movano Inc. (MOVE) Q3 2021 Results Earnings Conference Call November 11, 2021, 5:00 pm ET Company Participants J. Cogan - Chief Financial Officer John Mastrototaro - Chief Executive Officer Conference Call Participants Presentation Operator Greetings. Welcome to the Movano 3Q 2021 earnings co...
Movano (NASDAQ:MOVE): Q3 GAAP EPS of -$0.16. Press Release The Company had $39.3 million in cash, cash equivalents and short-term investments as of September 30, 2021, compared to $5.7 million in cash, cash equivalents and short-term investments, as of December 31, 2020. For further details...
Movano Inc. Provides Business Update and Reports Third Quarter 2021 Financial Results Conference call begins at 2:00 p.m. Pacific time today PR Newswire PLEASANTON, Calif. , Nov. 11, 2021 /PRNewswire/ -- Today, Movano Inc . (NASDAQ:MOVE), a health technol...
Movano Inc. to Participate in Bernstein CGM Disruptors Conference on Friday, November 19, 2021 PR Newswire PLEASANTON, Calif. , Nov. 9, 2021 /PRNewswire/ -- Movano Inc . (NASDAQ: MOVE), a health technology company designing devices that empower individual...
Movano Inc. to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 PR Newswire PLEASANTON, Calif. , Oct. 14, 2021 /PRNewswire/ -- Movano Inc . (NASDAQ:MOVE), a health technology company designing devices that empower individuals...
Conference call begins at 2:00 p.m. Pacific time today PLEASANTON, CA / ACCESSWIRE / August 12, 2021 / Today, Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that empower individuals to optimize their health in order to help prevent and better manage chronic dis...
PLEASANTON, CA / ACCESSWIRE / July 14, 2021 / Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that empower individuals to optimize their health to help prevent and better manage chronic diseases, today announced that it will report second quarter 2021 financial and...
After recently receiving IRB-approval to perform blood pressure studies in the Movano Clinical Lab, the Company used its investigational wrist-worn device to perform initial accuracy testing PLEASANTON, CA / ACCESSWIRE / July 6, 2021 / Movano Inc . (NASDAQ:MOVE), a health technology co...
News, Short Squeeze, Breakout and More Instantly...
Movano Health Announces Dr. Fatima Rodriguez Joining July 11 Virtual Event PR Newswire Allele Capitals' Matt Hughes will moderate future forward panel on enterprise need in wearables for a variety of healthcare applications PLEASANTON, Calif. , June 28, 2...
Movano Health Applies Advanced AI through Deep Learning to Deliver Improved Accuracy of Heart Rate in Motion PR Newswire Enhancements address significant clinical enterprise need in wearables for a variety of healthcare applications PLEASANTON, Calif. , June 13, 20...
MIT Selects Movano Health for Groundbreaking Study on Long COVID and Chronic Lyme Disease PR Newswire Pioneering partnership advances innovative health monitoring, setting the stage for future enterprise opportunities. PLEASANTON, Calif. , June 10, 2024 ...